行业机构报告:华为、OPPO及Vivo较受中国疫情冲击
行业研究机构Counterpoint发表报告,中国智能手机首季销售受疫情影响而大减,华为将是最受冲击的手机生产商之一,OPPO及Vivo亦因高度依赖线下销售渠道而受影响。小米(01810.HK)、一加及Realme受影响程度较低,因该等公司更着重网售及海外市场。
机构下调疫情期间中国线下智能手机销量预测一半,并下调首季整体销量预测两成。机构预期疫情将於3月受控,但中国商业活动完全恢复正常可能需要两个月,预计中国及全球首两季智能手机市场将出现负增长。
该机构亦预计疫情使苹果iPhone销量减少100万部。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.